Delivra Health Brands Inc.
DHBUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.02 | 0.21 | 0.01 |
| FCF Yield | -9.51% | 7.74% | -30.14% | -69.67% |
| EV / EBITDA | 38.28 | 3.22 | 2.14 | -1.75 |
| Quality | ||||
| ROIC | -8.46% | -9.83% | -25.50% | -116.97% |
| Gross Margin | 50.70% | 51.70% | 49.26% | 31.99% |
| Cash Conversion Ratio | 0.47 | 0.86 | 5.91 | 0.63 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.94% | 15.00% | 7.16% | -0.98% |
| Free Cash Flow Growth | -173.26% | 166.96% | 74.70% | 53.89% |
| Safety | ||||
| Net Debt / EBITDA | -2.17 | -0.92 | -0.55 | -0.24 |
| Interest Coverage | -7.13 | -4.20 | -5.45 | -10.09 |
| Efficiency | ||||
| Inventory Turnover | 2.39 | 4.05 | 2.20 | 2.49 |
| Cash Conversion Cycle | 189.53 | 133.81 | 107.29 | -13.26 |